Oskar Hansson is an experienced professional in the field of neurology, currently serving as the Vice President of Neurodegenerative Disease Early Phase Clinical Development and Imaging Development at Eli Lilly and Company since November 2024. Concurrently, Oskar holds several academic positions at Lund University, including Professor of Neurology, Vice Director for the ProActive Aging Profile Area, and Vice Coordinator of the strategic neuroscience network MultiPark, roles held since January 2014. Prior to these positions, Oskar served as a Senior Consultant in Neurology at Skåne University Hospital from January 2012 to November 2024. Oskar's educational background includes a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD) in Neurobiology and Neurosciences, both obtained from Lund University, along with a degree from the Biomedical Research School in Biomedical Sciences.
This person is not in any teams
This person is not in any offices